Influence of therapy with trimetazidine on the state of the main vessels and microcirculation in patients with CHF and DM type 2. The results of the original study

by M. E. Statsenko, S. V. Fabritskaya, U. A. Ryndina
Published 2018-04-01

NEW POTENTIAL OF PHARMACEUTICAL CORRECTION OF CARDIAC AUTONOMIC NEUROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC HEART FAILURE

by M. E. Statsenko, S. V. Turkina, S. S. Shalaeva, S. V. Fabritskaya
Published 2011-10-01

THE EFFICACY OF MELDONIUM IN PATIENTS WITH CHRONIC HEART FAILURE OF ISCHEMIC ETIOLOGY WITH COMORBIDITIES

by M. E. Statsenko, S. V. Turkina, S. V. Fabritskaya, I. A. Tyschenko, L. V. Poletayeva
Published 2017-12-01

CARDIONATE IN COMBINED THERAPY OF ISCHEMIC CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROME

by M. E. Statsenko, S. V. Turkina, E. D. Evtereva, O. E. Sporova, S. V. Fabritskaya
Published 2010-08-01

NEW POTENTIAL OF MEXICOR IN THE TREATMENT OF CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROME

by M. E. Statsenko, E. D. Evtereva, S. V. Turkina, S. V. Fabritskaya, O. E. Sporova
Published 2010-12-01